Bullish option flow detected in Crispr Therapeutics (CRSP) with 4,723 calls trading, 2x expected, and implied vol increasing over 3 points to 63.50%. Jul-25 35 calls and Jul-25 70 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.19. Earnings are expected on May 7th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Biotech stocks slide as Marks resignation seen being negative for sector
- BMO says Peter Marks resignation ‘significant negative’ for biotech
- Vaccine, gene therapy makers fall after Peter Marks resignation
- CRISPR Therapeutics COO Julianne Bruno Resigns
- Crispr Therapeutics COO Julianne Bruno to step down